FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136898696> ?p ?o ?g. }

• W3136898696 endingPage "3217" @default.
• W3136898696 startingPage "3212" @default.
• W3136898696 abstract "Abstract Relapsed myeloid disease after allogeneic stem cell transplantation (HSCT) remains largely incurable. We previously demonstrated the potent activity of immune checkpoint blockade in this clinical setting with ipilimumab or nivolumab. To define the molecular and cellular pathways by which CTLA-4 blockade with ipilimumab can reinvigorate an effective graft-versus-leukemia (GVL) response, we integrated transcriptomic analysis of leukemic biopsies with immunophenotypic profiling of matched peripheral blood samples collected from patients treated with ipilimumab following HSCT on the Experimental Therapeutics Clinical Trials Network 9204 trial. Response to ipilimumab was associated with transcriptomic evidence of increased local CD8+ T-cell infiltration and activation. Systemically, ipilimumab decreased naïve and increased memory T-cell populations and increased expression of markers of T-cell activation and costimulation such as PD-1, HLA-DR, and ICOS, irrespective of response. However, responding patients were characterized by higher turnover of T-cell receptor sequences in peripheral blood and showed increased expression of proinflammatory chemokines in plasma that was further amplified by ipilimumab. Altogether, these data highlight the compositional T-cell shifts and inflammatory pathways induced by ipilimumab both locally and systemically that associate with successful GVL outcomes. This trial was registered at www.clinicaltrials.gov as #NCT01822509." @default.
• W3136898696 created "2021-03-29" @default.
• W3136898696 creator A5001407163 @default.
• W3136898696 creator A5003022407 @default.
• W3136898696 creator A5003830250 @default.
• W3136898696 creator A5003947352 @default.
• W3136898696 creator A5008718116 @default.
• W3136898696 creator A5009765944 @default.
• W3136898696 creator A5010175337 @default.
• W3136898696 creator A5014161341 @default.
• W3136898696 creator A5022172869 @default.
• W3136898696 creator A5026296388 @default.
• W3136898696 creator A5029278364 @default.
• W3136898696 creator A5029390145 @default.
• W3136898696 creator A5031812464 @default.
• W3136898696 creator A5043167176 @default.
• W3136898696 creator A5044544424 @default.
• W3136898696 creator A5044979045 @default.
• W3136898696 creator A5045479163 @default.
• W3136898696 creator A5047701430 @default.
• W3136898696 creator A5051935412 @default.
• W3136898696 creator A5054037976 @default.
• W3136898696 creator A5054970583 @default.
• W3136898696 creator A5055590197 @default.
• W3136898696 creator A5056686039 @default.
• W3136898696 creator A5057562254 @default.
• W3136898696 creator A5058975989 @default.
• W3136898696 creator A5061431553 @default.
• W3136898696 creator A5063755644 @default.
• W3136898696 creator A5065102493 @default.
• W3136898696 creator A5068050082 @default.
• W3136898696 creator A5071407925 @default.
• W3136898696 creator A5071627875 @default.
• W3136898696 creator A5072485141 @default.
• W3136898696 creator A5072688213 @default.
• W3136898696 creator A5078046623 @default.
• W3136898696 creator A5084424357 @default.
• W3136898696 creator A5084967339 @default.
• W3136898696 creator A5085713254 @default.
• W3136898696 creator A5090809833 @default.
• W3136898696 date "2021-03-16" @default.
• W3136898696 modified "2023-10-16" @default.
• W3136898696 title "Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation" @default.
• W3136898696 cites W1978474777 @default.
• W3136898696 cites W2010084870 @default.
• W3136898696 cites W2049126749 @default.
• W3136898696 cites W2102862705 @default.
• W3136898696 cites W2345485155 @default.
• W3136898696 cites W2465734185 @default.
• W3136898696 cites W2558219863 @default.
• W3136898696 cites W2733520933 @default.
• W3136898696 cites W2797069917 @default.
• W3136898696 cites W2906119683 @default.
• W3136898696 cites W2908841748 @default.
• W3136898696 cites W2923555931 @default.
• W3136898696 cites W2923660448 @default.
• W3136898696 cites W2962729112 @default.
• W3136898696 cites W2972096813 @default.
• W3136898696 cites W2982252373 @default.
• W3136898696 cites W3001831084 @default.
• W3136898696 cites W3029963315 @default.
• W3136898696 cites W3039498654 @default.
• W3136898696 cites W3107635367 @default.
• W3136898696 doi "https://doi.org/10.1182/blood.2021010867" @default.
• W3136898696 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8351891" @default.
• W3136898696 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33720354" @default.
• W3136898696 hasPublicationYear "2021" @default.
• W3136898696 type Work @default.
• W3136898696 sameAs 3136898696 @default.
• W3136898696 citedByCount "18" @default.
• W3136898696 countsByYear W31368986962021 @default.
• W3136898696 countsByYear W31368986962022 @default.
• W3136898696 countsByYear W31368986962023 @default.
• W3136898696 crossrefType "journal-article" @default.
• W3136898696 hasAuthorship W3136898696A5001407163 @default.
• W3136898696 hasAuthorship W3136898696A5003022407 @default.
• W3136898696 hasAuthorship W3136898696A5003830250 @default.
• W3136898696 hasAuthorship W3136898696A5003947352 @default.
• W3136898696 hasAuthorship W3136898696A5008718116 @default.
• W3136898696 hasAuthorship W3136898696A5009765944 @default.
• W3136898696 hasAuthorship W3136898696A5010175337 @default.
• W3136898696 hasAuthorship W3136898696A5014161341 @default.
• W3136898696 hasAuthorship W3136898696A5022172869 @default.
• W3136898696 hasAuthorship W3136898696A5026296388 @default.
• W3136898696 hasAuthorship W3136898696A5029278364 @default.
• W3136898696 hasAuthorship W3136898696A5029390145 @default.
• W3136898696 hasAuthorship W3136898696A5031812464 @default.
• W3136898696 hasAuthorship W3136898696A5043167176 @default.
• W3136898696 hasAuthorship W3136898696A5044544424 @default.
• W3136898696 hasAuthorship W3136898696A5044979045 @default.
• W3136898696 hasAuthorship W3136898696A5045479163 @default.
• W3136898696 hasAuthorship W3136898696A5047701430 @default.
• W3136898696 hasAuthorship W3136898696A5051935412 @default.
• W3136898696 hasAuthorship W3136898696A5054037976 @default.
• W3136898696 hasAuthorship W3136898696A5054970583 @default.
• W3136898696 hasAuthorship W3136898696A5055590197 @default.
• W3136898696 hasAuthorship W3136898696A5056686039 @default.
• W3136898696 hasAuthorship W3136898696A5057562254 @default.

• next